American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 159-165, (2002)
© 2002 American Thoracic Society
Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea
A 7-Year Follow-up
Yüksel Peker,
Jan Hedner,
Jeanette Norum,
Holger Kraiczi and
Jan Carlson
Sleep Laboratory, Department of Pulmonary Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
Correspondence and requests for reprints should be addressed to Yüksel Peker, M.D., Ph.D., Department of Pulmonary Medicine, Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden. E-mail: yuksel.peker{at}lungall.gu.se
The incidence of a cardiovascular disease (CVD) was explored in a consecutive sleep clinic cohort of 182 middle-aged men (mean age, 46.8 ± 9.3; range, 3069 years in 1991) with or without obstructive sleep apnea (OSA). All subjects were free of hypertension or other CVD, pulmonary disease, diabetes mellitus, psychiatric disorder, alcohol dependency, as well as malignancy at baseline. Data were collected via the Swedish Hospital Discharge Register covering a 7-year period before December 31, 1998, as well as questionnaires. Effectiveness of OSA treatment initiated during the period as well as age, body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP) at baseline, and smoking habits were controlled. The incidence of at least one CVD was observed in 22 of 60 (36.7%) cases with OSA (overnight oxygen desaturations of 30 or more) compared with in 8 of 122 (6.6%) subjects without OSA (p < 0.001). In a multiple logistic regression model, significant predictors of CVD incidence were OSA at baseline (odds ratio [OR] 4.9; 95% confidence interval [CI], 1.813.6) and age (OR 23.4; 95% CI, 2.7197.5) after adjustment for BMI, SBP, and DBP at baseline. In the OSA group, CVD incidence was observed in 21 of 37 (56.8%) incompletely treated cases compared with in 1 of 15 (6.7%) efficiently treated subjects (p < 0.001). In a multiple regression analysis, efficient treatment was associated with a significant risk reduction for CVD incidence (OR 0.1; 95% CI, 0.00.7) after adjustment for age and SBP at baseline in the OSA subjects. We conclude that the risk of developing CVD is increased in middle-aged OSA subjects independently of age, BMI, SBP, DBP, and smoking. Furthermore, efficient treatment of OSA reduces the excess CVD risk and may be considered also in relatively mild OSA without regard to daytime sleepiness.
Key Words: sleep apnea cardiovascular hypertension risk factor
This article has been cited by other articles:

|
 |

|
 |
 
H. A Chami, M. J Keyes, J. A Vita, G. F Mitchell, M. G Larson, S. Fan, R. S Vasan, G. T O'Connor, E. J Benjamin, and D. J Gottlieb
Brachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing
Vascular Medicine,
November 1, 2009;
14(4):
351 - 360.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kumagai, T. Kasai, M. Kato, R. Naito, K.-i. Maeno, S. Kasagi, F. Kawana, S. Ishiwata, and K. Narui
Establishment of the Cardio-Ankle Vascular Index in Patients With Obstructive Sleep Apnea
Chest,
September 1, 2009;
136(3):
779 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Ryan, C T Taylor, and W T McNicholas
Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?
Thorax,
July 1, 2009;
64(7):
631 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Ayers, B. Ferry, S. Craig, D. Nicoll, J. R. Stradling, and M. Kohler
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Eur. Respir. J.,
March 1, 2009;
33(3):
574 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Kohler, L Ayers, J C T Pepperell, K L Packwood, B Ferry, N Crosthwaite, S Craig, M M Siccoli, R J O Davies, and J R Stradling
Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial
Thorax,
January 1, 2009;
64(1):
67 - 73.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kohler, J. C. T. Pepperell, B. Casadei, S. Craig, N. Crosthwaite, J. R. Stradling, and R. J. O. Davies
CPAP and measures of cardiovascular risk in males with OSAS
Eur. Respir. J.,
December 1, 2008;
32(6):
1488 - 1496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kohler, S. Craig, D. Nicoll, P. Leeson, R. J. O. Davies, and J. R. Stradling
Endothelial Function and Arterial Stiffness in Minimally Symptomatic Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
November 1, 2008;
178(9):
984 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Chandrashekariah, Z. Shaman, and D. Auckley
Impact of Upper Airway Surgery on CPAP Compliance in Difficult-to-Manage Obstructive Sleep Apnea
Arch Otolaryngol Head Neck Surg,
September 1, 2008;
134(9):
926 - 930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Phillips, B. Yee, Q. Yang, A. T. Villaneuva, J. Hedner, N. Berend, and R. Grunstein
Effects of Continuous Positive Airway Pressure Treatment and Withdrawal in Patients With Obstructive Sleep Apnea on Arterial Stiffness and Central BP
Chest,
July 1, 2008;
134(1):
94 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. Chami, R. B. Devereux, J. S. Gottdiener, R. Mehra, M. J. Roman, E. J. Benjamin, and D. J. Gottlieb
Left Ventricular Morphology and Systolic Function in Sleep-Disordered Breathing: The Sleep Heart Health Study
Circulation,
May 20, 2008;
117(20):
2599 - 2607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Lopez-Jimenez, F. H. Sert Kuniyoshi, A. Gami, and V. K. Somers
Obstructive Sleep Apnea: Implications for Cardiac and Vascular Disease
Chest,
March 1, 2008;
133(3):
793 - 804.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. McNicholas
Diagnosis of Obstructive Sleep Apnea in Adults
Proceedings of the ATS,
February 15, 2008;
5(2):
154 - 160.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Sanders, J. M. Montserrat, R. Farre, and R. J. Givelber
Positive Pressure Therapy: A Perspective on Evidence-based Outcomes and Methods of Application
Proceedings of the ATS,
February 15, 2008;
5(2):
161 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Reuveni, S. Greenberg-Dotan, T. Simon-Tuval, A. Oksenberg, and A. Tarasiuk
Elevated healthcare utilisation in young adult males with obstructive sleep apnoea
Eur. Respir. J.,
February 1, 2008;
31(2):
273 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Dujic, V. Ivancev, K. Heusser, G. Dzamonja, I. Palada, Z. Valic, J. Tank, A. Obad, D. Bakovic, A. Diedrich, et al.
Central chemoreflex sensitivity and sympathetic neural outflow in elite breath-hold divers
J Appl Physiol,
January 1, 2008;
104(1):
205 - 211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Amit Benjamin and K E Lewis
Sleep-disordered breathing and cardiovascular disease
Postgrad. Med. J.,
January 1, 2008;
84(987):
15 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Buchner, B. M. Sanner, J. Borgel, and L. C. Rump
Continuous Positive Airway Pressure Treatment of Mild to Moderate Obstructive Sleep Apnea Reduces Cardiovascular Risk
Am. J. Respir. Crit. Care Med.,
December 15, 2007;
176(12):
1274 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Boudewyns, M. Marklund, and W. Hochban
Alternatives for OSAHS treatment: selection of patients for upper airway surgery and oral appliances
Eur. Respir. Rev.,
December 1, 2007;
16(106):
132 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Troncoso Brindeiro, A. Q. da Silva, K. J. Allahdadi, V. Youngblood, and N. L. Kanagy
Reactive oxygen species contribute to sleep apnea-induced hypertension in rats
Am J Physiol Heart Circ Physiol,
November 1, 2007;
293(5):
H2971 - H2976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. McNicholas
Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2007;
293(4):
R1666 - R1670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Parati, C. Lombardi, and K. Narkiewicz
Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk
Am J Physiol Regulatory Integrative Comp Physiol,
October 1, 2007;
293(4):
R1671 - R1683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Kakkar and R. B. Berry
Positive Airway Pressure Treatment for Obstructive Sleep Apnea
Chest,
September 1, 2007;
132(3):
1057 - 1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Steiropoulos, V. Tsara, E. Nena, C. Fitili, M. Kataropoulou, M. Froudarakis, P. Christaki, and D. Bouros
Effect of Continuous Positive Airway Pressure Treatment on Serum Cardiovascular Risk Factors in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome
Chest,
September 1, 2007;
132(3):
843 - 851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. El Solh, M. E. Akinnusi, F. H. Baddoura, and C. R. Mankowski
Endothelial Cell Apoptosis in Obstructive Sleep Apnea: A Link to Endothelial Dysfunction
Am. J. Respir. Crit. Care Med.,
June 1, 2007;
175(11):
1186 - 1191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Venkateswaran and P. Shankar
The prevalence of syndrome Z (the interaction of obstructive sleep apnoea with the metabolic syndrome) in a teaching hospital in Singapore
Postgrad. Med. J.,
May 1, 2007;
83(979):
329 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Coughlin, L. Mawdsley, J. A. Mugarza, J. P. H. Wilding, and P. M. A. Calverley
Cardiovascular and metabolic effects of CPAP in obese males with OSA
Eur. Respir. J.,
April 1, 2007;
29(4):
720 - 727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, N. Oda, A. Tanaka, M. Yamamoto, S. Ohta, C. P. O'Donnell, and M. Adachi
Silent Brain Infarction and Platelet Activation in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
March 15, 2007;
175(6):
612 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Itzhaki, H. Dorchin, G. Clark, L. Lavie, P. Lavie, and G. Pillar
The Effects of 1-Year Treatment With a Herbst Mandibular Advancement Splint on Obstructive Sleep Apnea, Oxidative Stress, and Endothelial Function
Chest,
March 1, 2007;
131(3):
740 - 749.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Oldenburg, B. Lamp, L. Faber, H. Teschler, D. Horstkotte, and V. Topfer
Sleep-disordered breathing in patients with symptomatic heart failure A contemporary study of prevalence in and characteristics of 700 patients
Eur J Heart Fail,
March 1, 2007;
9(3):
251 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. McArdle, D. Hillman, L. Beilin, and G. Watts
Metabolic Risk Factors for Vascular Disease in Obstructive Sleep Apnea: A Matched Controlled Study
Am. J. Respir. Crit. Care Med.,
January 15, 2007;
175(2):
190 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. McNicholas, M. R. Bonsignore, and the Management Committee of EU COST ACTION B26
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
Eur. Respir. J.,
January 1, 2007;
29(1):
156 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Johansson, P. Eriksson, Y. Peker, J. Hedner, L. Rastam, and U. Lindblad
The influence of patent foramen ovale on oxygen desaturation in obstructive sleep apnoea
Eur. Respir. J.,
January 1, 2007;
29(1):
149 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D S Hui, K W To, F W Ko, J P Fok, M C Chan, J C Ngai, A H Tung, C W Ho, M W Tong, C-C Szeto, et al.
Nasal CPAP reduces systemic blood pressure in patients with obstructive sleep apnoea and mild sleepiness
Thorax,
December 1, 2006;
61(12):
1083 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Kezirian, E. M. Weaver, B. Yueh, S. F. Khuri, J. Daley, and W. G. Henderson
Risk factors for serious complication after uvulopalatopharyngoplasty.
Arch Otolaryngol Head Neck Surg,
October 1, 2006;
132(10):
1091 - 1098.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Hiestand, P. Britz, M. Goldman, and B. Phillips
Prevalence of Symptoms and Risk of Sleep Apnea in the US Population: Results From the National Sleep Foundation Sleep in America 2005 Poll.
Chest,
September 1, 2006;
130(3):
780 - 786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Peker, J. Carlson, and J. Hedner
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Eur. Respir. J.,
September 1, 2006;
28(3):
596 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Minoguchi, T. Yokoe, A. Tanaka, S. Ohta, T. Hirano, G. Yoshino, C. P. O'Donnell, and M. Adachi
Association between lipid peroxidation and inflammation in obstructive sleep apnoea.
Eur. Respir. J.,
August 1, 2006;
28(2):
378 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cashman
Case Study: Sleep Apnea Diagnosis in a Man With Type 2 Diabetes Improved Control
Diabetes Spectr,
July 1, 2006;
19(3):
190 - 192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N T Ayas, G B J Mancini, and J Fleetham
Does CPAP delay the development of cardiovascular disease in patients with obstructive sleep apnoea hypopnoea?
Thorax,
June 1, 2006;
61(6):
459 - 460.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. T. Ayas, J. M. FitzGerald, J. A. Fleetham, D. P. White, M. Schulzer, C. F. Ryan, R. Ghaeli, G. W. Mercer, P. Cooper, M. C. Y. Tan, et al.
Cost-effectiveness of Continuous Positive Airway Pressure Therapy for Moderate to Severe Obstructive Sleep Apnea/Hypopnea.
Arch Intern Med,
May 8, 2006;
166(9):
977 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. El Solh, R. Saliba, T. Bosinski, B. J. B. Grant, E. Berbary, and N. Miller
Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study.
Eur. Respir. J.,
May 1, 2006;
27(5):
997 - 1002.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Martinez-Garcia, R. Galiano-Blancart, J.-J. Soler-Cataluna, L. Cabero-Salt, and P. Roman-Sanchez
Improvement in nocturnal disordered breathing after first-ever ischemic stroke: role of Dysphagia.
Chest,
February 1, 2006;
129(2):
238 - 245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ryan, C. T. Taylor, and W. T. McNicholas
Selective Activation of Inflammatory Pathways by Intermittent Hypoxia in Obstructive Sleep Apnea Syndrome
Circulation,
October 25, 2005;
112(17):
2660 - 2667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Bassetti
Obstructive Sleep Apnea and Atherosclerosis: "Guilt by Association"
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
518 - 519.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Minoguchi, T. Yokoe, T. Tazaki, H. Minoguchi, A. Tanaka, N. Oda, S. Okada, S. Ohta, H. Naito, and M. Adachi
Increased Carotid Intima-Media Thickness and Serum Inflammatory Markers in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
625 - 630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Drager, L. A. Bortolotto, M. C. Lorenzi, A. C. Figueiredo, E. M. Krieger, and G. Lorenzi-Filho
Early Signs of Atherosclerosis in Obstructive Sleep Apnea
Am. J. Respir. Crit. Care Med.,
September 1, 2005;
172(5):
613 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C F Ryan
Sleep {middle dot} 9: An approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery
Thorax,
July 1, 2005;
60(7):
595 - 604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Luthje, C. Unterberg-Buchwald, D. Dajani, D. Vollmann, G. Hasenfuss, and S. Andreas
Atrial Overdrive Pacing in Patients with Sleep Apnea with Implanted Pacemaker
Am. J. Respir. Crit. Care Med.,
July 1, 2005;
172(1):
118 - 122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. S. Doherty, J. L. Kiely, V. Swan, and W. T. McNicholas
Long-term Effects of Nasal Continuous Positive Airway Pressure Therapy on Cardiovascular Outcomes in Sleep Apnea Syndrome
Chest,
June 1, 2005;
127(6):
2076 - 2084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Lam, M S M Ip, E Tench, and C F Ryan
Craniofacial profile in Asian and white subjects with obstructive sleep apnoea
Thorax,
June 1, 2005;
60(6):
504 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Lavie, L. Lavie, and P. Herer
All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age
Eur. Respir. J.,
March 1, 2005;
25(3):
514 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Strike and A. Steptoe
Behavioral and Emotional Triggers of Acute Coronary Syndromes: A Systematic Review and Critique
Psychosom Med,
March 1, 2005;
67(2):
179 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alonso-Fernandez, F. Garcia-Rio, M. A. Racionero, J. M. Pino, F. Ortuno, I. Martinez, and J. Villamor
Cardiac Rhythm Disturbances and ST-Segment Depression Episodes in Patients With Obstructive Sleep Apnea-Hypopnea Syndrome and Its Mechanisms
Chest,
January 1, 2005;
127(1):
15 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tazaki, K. Minoguchi, T. Yokoe, K. T. R. Samson, H. Minoguchi, A. Tanaka, Y. Watanabe, and M. Adachi
Increased Levels and Activity of Matrix Metalloproteinase-9 in Obstructive Sleep Apnea Syndrome
Am. J. Respir. Crit. Care Med.,
December 15, 2004;
170(12):
1354 - 1359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G V Robinson, J C T Pepperell, H C Segal, R J O Davies, and J R Stradling
Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials
Thorax,
September 1, 2004;
59(9):
777 - 782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Grote
Stroke alert: sleep disordered breathing predicts survival?
Eur. Respir. J.,
August 1, 2004;
24(2):
195 - 196.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Olson, E. J. Olson, and V. K. Somers
Obstructive Sleep Apnea and Platelet Activation: Another Potential Link Between Sleep-Disordered Breathing and Cardiovascular Disease
Chest,
August 1, 2004;
126(2):
339 - 341.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Strike, K. Magid, L. Brydon, S. Edwards, J. R. McEwan, and A. Steptoe
Exaggerated Platelet and Hemodynamic Reactivity to Mental Stress in Men With Coronary Artery Disease
Psychosom Med,
July 1, 2004;
66(4):
492 - 500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Gami, A. Svatikova, R. Wolk, E. J. Olson, C. J. Duenwald, A. S. Jaffe, and V. K. Somers
Cardiac Troponin T in Obstructive Sleep Apnea
Chest,
June 1, 2004;
125(6):
2097 - 2100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Milleron, R. Pilliere, A. Foucher, F. de Roquefeuil, P. Aegerter, G. Jondeau, B. G Raffestin, and O. Dubourg
Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study
Eur. Heart J.,
May 1, 2004;
25(9):
728 - 734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Hui, F. W. Ko, J. P. Fok, M. C. Chan, T. S. Li, B. Tomlinson, and G. Cheng
The Effects of Nasal Continuous Positive Airway Pressure on Platelet Activation in Obstructive Sleep Apnea Syndrome
Chest,
May 1, 2004;
125(5):
1768 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Amin, J. L. Carroll, J. L. Jeffries, C. Grone, J. A. Bean, B. Chini, R. Bokulic, and S. R. Daniels
Twenty-four-hour Ambulatory Blood Pressure in Children with Sleep-disordered Breathing
Am. J. Respir. Crit. Care Med.,
April 15, 2004;
169(8):
950 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. M. Ip, H.-F. Tse, B. Lam, K. W. T. Tsang, and W.-K. Lam
Endothelial Function in Obstructive Sleep Apnea and Response to Treatment
Am. J. Respir. Crit. Care Med.,
February 1, 2004;
169(3):
348 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Sampol, O. Romero, A. Salas, J. L. Tovar, P. Lloberes, T. Sagales, and A. Evangelista
Obstructive Sleep Apnea and Thoracic Aorta Dissection
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1528 - 1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wolk, A. S.M. Shamsuzzaman, and V. K. Somers
Obesity, Sleep Apnea, and Hypertension
Hypertension,
December 1, 2003;
42(6):
1067 - 1074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ancoli-Israel, E. R. DuHamel, C. Stepnowsky, R. Engler, M. Cohen-Zion, and M. Marler
The Relationship Between Congestive Heart Failure, Sleep Apnea, and Mortality in Older Men
Chest,
October 1, 2003;
124(4):
1400 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Phillips
The JNC 7 Hypertension Guidelines
JAMA,
September 10, 2003;
290(10):
1314 - 1314.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Phillips
Definitions of the Metabolic Syndrome
JAMA,
March 12, 2003;
289(10):
1241 - 1241.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Sleep-Disordered Breathing, Control of Breathing, Respiratory Muscles, and Pulmonary Function Testing in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
306 - 318.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. I. Pack
Should a Pharmaceutical Be Approved for the Broad Indication of Excessive Sleepiness?
Am. J. Respir. Crit. Care Med.,
January 15, 2003;
167(2):
109 - 111.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Spoken sessions
Thorax,
December 1, 2002;
57(90003):
iii3 - 47.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Kuna
A 54-Year-Old Man With Obstructive Sleep Apnea
JAMA,
October 23, 2002;
288(16):
2032 - 2039.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|